PER 10.0% 11.0¢ percheron therapeutics limited

chart, page-85

  1. 374 Posts.
    Excellent post Sam.
    Perhaps the company has been to focused on developing the pipeline, a perceived expectation of "you build it they will come"?
    You will never be found if you don't make a presence for yourself.
    The biggest misses IMO
    - the ISIS link
    - specific market awareness/saturation i.e poor/slow enrolment for phII ATL1103. Should've had patients waiting to trial.
    - increase investor base via 3rd party finance reviews/broker recommendations/reports, heightened media exposure, create social media channels.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.